SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITEDActive
Key figures
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2022Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £7,507,000 (90% of the profit for the year).
Filed accounts2021–2022
| 2021 | 2022 | |
|---|---|---|
| Profit for the year | 8,348,000 | 539,000 |
| Total assets | — | — |
| Total liabilities | 4,222,000 | 4,622,000 |
| Net assets / total equity | 29,342,000 | 29,881,000 |
| Average number of employees | 0 | 0 |
| Dividends paid | 7,507,000 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2022Being a holding company, the only risk facing the entity is the risk of impairment of the carrying value of investments in subsidiary entities.
As described in the company's latest filed accounts.
Summary: SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED
Company
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED is a private limited company registered with Companies House under company number 09389074. It was incorporated on 14 Jan 2015. Its status is active. The registered office is in Cambridge (CB21). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2022 (period ending 31 Dec 2022); the company files full accounts. Profit for the year was £539,000. Net assets were £29,881,000, up 1.8% on the previous year. The company had an average of 0 employees. Figures are available for 2 financial years (2021–2022).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 28 Jan 2027.